ABT-737 and ABT-263 are capable of inducing rapid disruption of both Bcl-2/Bax and Bcl-2/Bik complexes in MCL cells and if these cells express the characteristic Bcl-2high/Mcl-1low profile. Here, BCL2 is linked to mantle cell lymphoma.